Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
Ticker SymbolSMLR
Company nameSemler Scientific Inc
IPO dateFeb 27, 2014
CEODr. Douglas Murphy Chutorian, M.D.
Number of employees79
Security typeOrdinary Share
Fiscal year-endFeb 27
Address51 E Campbell Ave
CityCAMPBELL
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code95008
Phone18777744211
Websitehttps://www.semlerscientific.com/
Ticker SymbolSMLR
IPO dateFeb 27, 2014
CEODr. Douglas Murphy Chutorian, M.D.
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data